^
BIOMARKER:

CD14 overexpression

i
Other names: CD14
Entrez ID:
Related biomarkers:
CD14 overexpression
HL
nivolumab + brentuximab vedotin
Sensitive: C3 – Early Trials
CD14 overexpression
AML
venetoclax + palbociclib
Sensitive: C3 – Early Trials